Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2019
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized StudyRob Pieters, Paola De Lorenzo, Philip Ancliffe, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALLAngus Hodder, Avijeet K Mishra, Amir Enshaei, et al.
Leukemia|June 27, 2021
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysisLinea N Toksvang, Kathrine Grell, Jacob Nersting, et al.
Experimental Hematology|March 31, 2004
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choiceEliane Gluckman, Vanderson Rocha, William Arcese, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Blood|December 19, 2012
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow TransplantationThomas Daikeler, Myriam Labopin, Annalisa Ruggeri, et al.
British Journal of Haematology|September 14, 2020
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusionAnthony V Moorman, Claire Schwab, Emily Winterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2019
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized StudyRob Pieters, Paola De Lorenzo, Philip Ancliffe, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALLAngus Hodder, Avijeet K Mishra, Amir Enshaei, et al.
Leukemia|June 27, 2021
DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysisLinea N Toksvang, Kathrine Grell, Jacob Nersting, et al.
Experimental Hematology|March 31, 2004
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choiceEliane Gluckman, Vanderson Rocha, William Arcese, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
The Lancet. Haematology|December 28, 2020
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort studyMonique L den Boer, Gunnar Cario, Anthony V Moorman, et al.
Blood|December 19, 2012
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow TransplantationThomas Daikeler, Myriam Labopin, Annalisa Ruggeri, et al.
British Journal of Haematology|September 14, 2020
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusionAnthony V Moorman, Claire Schwab, Emily Winterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Pageof 17